(Q53943435)

22 May 2018

title

Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin after single and multiple subcutaneous doses to healthy subjects. (English)

1 reference

22 May 2018

1 reference

1 reference

1 reference

Cheung WK

1

1 reference

22 May 2018

Goon BL

series ordinal

2

1 reference

22 May 2018

Guilfoyle MC

series ordinal

3

1 reference

22 May 2018

Wacholtz MC

series ordinal

4

1 reference

22 May 2018

language of work or name

English

0 references

publication date

1 October 1998

1 reference

22 May 2018

Clinical Pharmacology & Therapeutics

published in

1 reference

22 May 2018

volume

64

1 reference

22 May 2018

issue

4

1 reference

22 May 2018

page(s)

412-423

1 reference

22 May 2018

Human marrow erythropoiesis in culture: II. Heterogeneity in the morphology, time course of colony formation, and sedimentation velocities of the colony-forming cells

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990072-8

The pharmacokinetics of recombinant human erythropoietin after intravenous and subcutaneous administration to healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990072-8

Isolation and characterization of genomic and cDNA clones of human erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990072-8

Cloning and expression of the human erythropoietin gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990072-8

Erythropoietin: structure, control of production, and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990072-8

Effect of pure erythropoietin on DNA-synthesis by human marrow day 15 erythroid burst forming units in short-term liquid culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990072-8

Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990072-8

Intravenous versus subcutaneous dosing of epoetin: a review of the literature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990072-8

Epoetin alfa. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in nonrenal applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990072-8

Clinical pharmacokinetics of epoetin (recombinant human erythropoietin).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990072-8

Erythropoietin--the first 90 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990072-8

Kinetic evaluation of nonlinear drug elimination by a disposition decomposition analysis. Application to the analysis of the nonlinear elimination kinetics of erythropoietin in adult humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990072-8

Pharmacokinetics and erythropoietic response to human recombinant erythropoietin in healthy men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990072-8

Serum ferritin assay and iron status in chronic renal failure and haemodialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990072-8

10.1016/S0009-9236(98)90072-8

7 January 2021

Identifiers

DOI

1 reference

22 May 2018

PubMed ID

9797798

1 reference

22 May 2018